Blog
    Peptide SpotlightFor PatientsOctober 21, 2026

    Ipamorelin vs Sermorelin: Choosing a Growth Hormone Booster

    Compare Ipamorelin vs Sermorelin. Learn about their FDA status, how they trigger growth hormone, and what the clinical evidence actually says for each.

    What are these things, anyway?

    If you have been looking into ways to nudge your body into making more growth hormone, you have likely tripped over two names: ipamorelin and sermorelin. Both are what scientists call secretagogues. That is just a fancy way of saying they tell your brain to release its own stored growth hormone rather than injecting the hormone itself.

    While they both have the same end goal, they work like two different keys for the same lock. They also have very different track records in the lab. This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.

    The veteran: Sermorelin

    Sermorelin is the old pro in this space. It is a GHRH analog, which means it mimics the natural signal your body sends to the pituitary gland—the pea-sized master controller in your brain—to release growth hormone. It has a Grade: B+ because it has actually been through the rigors of FDA approval.

    Here is what makes it unique:

    • It plays by the rules: It preserves your body’s feedback loop. If your levels get too high, a chemical called somatostatin steps in to shut things down, preventing your levels from getting dangerously high.
    • It has a history: It was FDA-approved in 1990 and 1997 for testing and treating growth issues in children.
    • Brain health: There are two completed studies (RCTs) showing positive results for cognition, or how well your brain functions.

    You might wonder why it is hard to find if it was approved. The original manufacturer stopped making it in 2008 due to supply chain issues, not because it was unsafe.

    The specialist: Ipamorelin

    Ipamorelin, which has a Grade: B-, is a bit more targeted. It is a selective ghrelin receptor agonist. That means it mimics a different hormone (ghrelin) to trigger short bursts of growth hormone that last about two hours.

    Scientists like it because it is picky. It was the first compound found to be truly selective, meaning it triggers growth hormone without accidentally bumping up other things you might not want, like cortisol (the stress hormone) or prolactin.

    However, the evidence is a bit thinner here:

    • Limited results: It finished Phase II trials for stomach issues, but it failed to meet the goals for that specific use.
    • Missing data: There are no published high-quality studies (RCTs) proving it actually changes body composition, burns fat, or helps with athletic performance.
    • Safety flags: The FDA has raised concerns about the safety of making this in compounding pharmacies, and it is currently on the prohibited list for professional athletes (WADA).

    What we still don't know

    Scientists are still working on this one—turns out the human body is complicated. Who knew? We do not have any head-to-head studies comparing these two directly.

    Also, if you have seen people talking about mixing ipamorelin with other peptides like CJC-1295, keep in mind there is exactly zero high-quality evidence (RCTs) on that specific combination. We also lack large-scale Phase III data for sermorelin use in adults, as the main studies only involved small groups of people.

    How to move forward

    If you are trying to decide which path is right for your specific health needs, this is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.

    Because these compounds require a prescription and professional oversight, learning how to find a peptide prescriber is your best first step. A qualified professional can help you navigate the differences between an FDA-approved reference standard like sermorelin and a selective compound like ipamorelin.

    Referenced Peptides

    This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.